Approval · Notice of Compliance 29211 · 2022
ADEMPAS: Notice of Compliance 29211
Issued October 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29211
- Date
- October 13, 2022
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph (PM) regarding contraindications for the co-administration with other sCG stimulators and to migrate the PM to the 2020 Master Template format.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADEMPAS | Not yet assigned | — |